Nutrition in the critically ill patient

N R Webster, H F Galley

Research output: Contribution to journalLiterature review

Abstract

Critically ill patients are hypermetabolic and have increased nutrient requirements. Although it is assumed that nutritional support is beneficial in this group of patients there are no well designed clinical trials to test this hypothesis. The rationale for nutritional support, therefore, is based upon clinical judgement. Although it is not known how long a critically ill patient can tolerate what is effectively starvation, the loss of lean tissue which occurs in catabolic patients (20-40g nitrogen/day) suggests that depletion to a critical level may occur after 14 days. Total parenteral nutrition given to malnourished patients with gastrointestinal cancer for 7 to 10 days before surgery has been shown to decrease complications by about 10%. Wound healing and normal immune responses are dependent upon adequate nutrient intake, and it seems reasonable, therefore, to commence feeding as soon as possible. Earlier feeding may decrease length of stay and complication rates in both critically ill patients and following surgery. It has been shown in randomised controlled trials of both enteral and parenteral feeding in the critically ill, that current regimens are sub-optimal. Calorie intake was shown to be often considerably in excess of metabolic requirements alone, and variable study design has made comparisons impossible. Despite the lack of knowledge regarding even the most simple of nutritional requirements in these patients, the administration of specific micronutrients and specialised supplements has attracted attention, Again, many of these more recent studies are limited because of poor study design.

Original languageEnglish
Pages (from-to)373-379
Number of pages7
JournalJournal of the Royal College of Surgeons of Edinburgh
Volume45
Publication statusPublished - 2000

Keywords

  • enteral nutrition
  • glutamine
  • nutritional antioxidants
  • parenteral nutrition
  • IMMUNE-ENHANCING DIET
  • RANDOMIZED TRIAL
  • PARENTERAL-NUTRITION
  • SEPTIC COMPLICATIONS
  • CLINICAL-TRIAL
  • ENTERAL DIETS
  • WEIGHT-LOSS
  • METAANALYSIS
  • RESECTION
  • ARGININE

Cite this

Nutrition in the critically ill patient. / Webster, N R ; Galley, H F .

In: Journal of the Royal College of Surgeons of Edinburgh, Vol. 45, 2000, p. 373-379.

Research output: Contribution to journalLiterature review

@article{5a88cd010b1343b1b14287a1ee3e9003,
title = "Nutrition in the critically ill patient",
abstract = "Critically ill patients are hypermetabolic and have increased nutrient requirements. Although it is assumed that nutritional support is beneficial in this group of patients there are no well designed clinical trials to test this hypothesis. The rationale for nutritional support, therefore, is based upon clinical judgement. Although it is not known how long a critically ill patient can tolerate what is effectively starvation, the loss of lean tissue which occurs in catabolic patients (20-40g nitrogen/day) suggests that depletion to a critical level may occur after 14 days. Total parenteral nutrition given to malnourished patients with gastrointestinal cancer for 7 to 10 days before surgery has been shown to decrease complications by about 10{\%}. Wound healing and normal immune responses are dependent upon adequate nutrient intake, and it seems reasonable, therefore, to commence feeding as soon as possible. Earlier feeding may decrease length of stay and complication rates in both critically ill patients and following surgery. It has been shown in randomised controlled trials of both enteral and parenteral feeding in the critically ill, that current regimens are sub-optimal. Calorie intake was shown to be often considerably in excess of metabolic requirements alone, and variable study design has made comparisons impossible. Despite the lack of knowledge regarding even the most simple of nutritional requirements in these patients, the administration of specific micronutrients and specialised supplements has attracted attention, Again, many of these more recent studies are limited because of poor study design.",
keywords = "enteral nutrition, glutamine, nutritional antioxidants, parenteral nutrition, IMMUNE-ENHANCING DIET, RANDOMIZED TRIAL, PARENTERAL-NUTRITION, SEPTIC COMPLICATIONS, CLINICAL-TRIAL, ENTERAL DIETS, WEIGHT-LOSS, METAANALYSIS, RESECTION, ARGININE",
author = "Webster, {N R} and Galley, {H F}",
year = "2000",
language = "English",
volume = "45",
pages = "373--379",
journal = "Journal of the Royal College of Surgeons of Edinburgh",
issn = "0035-8835",
publisher = "Edinburgh University Press",

}

TY - JOUR

T1 - Nutrition in the critically ill patient

AU - Webster, N R

AU - Galley, H F

PY - 2000

Y1 - 2000

N2 - Critically ill patients are hypermetabolic and have increased nutrient requirements. Although it is assumed that nutritional support is beneficial in this group of patients there are no well designed clinical trials to test this hypothesis. The rationale for nutritional support, therefore, is based upon clinical judgement. Although it is not known how long a critically ill patient can tolerate what is effectively starvation, the loss of lean tissue which occurs in catabolic patients (20-40g nitrogen/day) suggests that depletion to a critical level may occur after 14 days. Total parenteral nutrition given to malnourished patients with gastrointestinal cancer for 7 to 10 days before surgery has been shown to decrease complications by about 10%. Wound healing and normal immune responses are dependent upon adequate nutrient intake, and it seems reasonable, therefore, to commence feeding as soon as possible. Earlier feeding may decrease length of stay and complication rates in both critically ill patients and following surgery. It has been shown in randomised controlled trials of both enteral and parenteral feeding in the critically ill, that current regimens are sub-optimal. Calorie intake was shown to be often considerably in excess of metabolic requirements alone, and variable study design has made comparisons impossible. Despite the lack of knowledge regarding even the most simple of nutritional requirements in these patients, the administration of specific micronutrients and specialised supplements has attracted attention, Again, many of these more recent studies are limited because of poor study design.

AB - Critically ill patients are hypermetabolic and have increased nutrient requirements. Although it is assumed that nutritional support is beneficial in this group of patients there are no well designed clinical trials to test this hypothesis. The rationale for nutritional support, therefore, is based upon clinical judgement. Although it is not known how long a critically ill patient can tolerate what is effectively starvation, the loss of lean tissue which occurs in catabolic patients (20-40g nitrogen/day) suggests that depletion to a critical level may occur after 14 days. Total parenteral nutrition given to malnourished patients with gastrointestinal cancer for 7 to 10 days before surgery has been shown to decrease complications by about 10%. Wound healing and normal immune responses are dependent upon adequate nutrient intake, and it seems reasonable, therefore, to commence feeding as soon as possible. Earlier feeding may decrease length of stay and complication rates in both critically ill patients and following surgery. It has been shown in randomised controlled trials of both enteral and parenteral feeding in the critically ill, that current regimens are sub-optimal. Calorie intake was shown to be often considerably in excess of metabolic requirements alone, and variable study design has made comparisons impossible. Despite the lack of knowledge regarding even the most simple of nutritional requirements in these patients, the administration of specific micronutrients and specialised supplements has attracted attention, Again, many of these more recent studies are limited because of poor study design.

KW - enteral nutrition

KW - glutamine

KW - nutritional antioxidants

KW - parenteral nutrition

KW - IMMUNE-ENHANCING DIET

KW - RANDOMIZED TRIAL

KW - PARENTERAL-NUTRITION

KW - SEPTIC COMPLICATIONS

KW - CLINICAL-TRIAL

KW - ENTERAL DIETS

KW - WEIGHT-LOSS

KW - METAANALYSIS

KW - RESECTION

KW - ARGININE

M3 - Literature review

VL - 45

SP - 373

EP - 379

JO - Journal of the Royal College of Surgeons of Edinburgh

JF - Journal of the Royal College of Surgeons of Edinburgh

SN - 0035-8835

ER -